Skip to main content

Provocative Erections

Also known as

Clinically induced erections, Diagnostic erections, Test erections, Pharmacologically induced erections, Visually induced erections.

Definition

Provocative erections refer to erections that are clinically induced for diagnostic testing purposes, often to differentiate between organic and psychogenic erectile dysfunction (ED) [1]. These erections are typically achieved through visual or pharmacological stimulation in a controlled clinical setting. The primary purpose of inducing provocative erections is to assess the physiological capacity of the penis to achieve and maintain an erection, providing valuable insights into the underlying causes of ED [2]. This diagnostic approach helps healthcare professionals understand the vascular and neurological integrity required for an erection, which can guide appropriate treatment strategies.

Clinical Context

Provocative erections are primarily utilized in the diagnostic workup of erectile dysfunction. They are particularly useful in distinguishing between organic (physical) and psychogenic (psychological) causes of ED [3]. For instance, if a patient can achieve a full erection during provocative testing, it suggests that the physiological mechanisms are intact, pointing towards a psychogenic origin for their ED. Conversely, a poor or absent response may indicate an underlying organic issue, such as vascular insufficiency or neurological damage [4].

Patient selection for provocative erection testing often includes individuals presenting with ED where the cause is unclear, or when a comprehensive physiological assessment is required. The procedure typically involves the use of visual sexual stimulation or intracavernosal injection of vasoactive drugs (e.g., papaverine, alprostadil, phentolamine) to induce an erection [5]. Devices like RigiScan are sometimes used in conjunction with provocative testing to objectively measure the frequency, rigidity, and duration of these induced erections, providing quantitative data for diagnosis [6]. The expected outcomes of such testing include a clearer understanding of the etiology of ED, which then informs personalized treatment plans, ranging from pharmacological interventions to surgical options.

Scientific Citation

[1] Goonawardena, S. A. (1997). Pharmacologically induced penile erections in the diagnosis of erectile dysfunction. British Journal of Urology, 80(2), 297-300. DOI: https://pubmed.ncbi.nlm.nih.gov/9257465/

[2] Kerfoot, W. W. (1991). Pharmacologically induced erections among geriatric men. Journal of Urology, 146(3), 681-683. DOI: https://pubmed.ncbi.nlm.nih.gov/1895417/

[3] Andersson, K. E. (2001). Pharmacology of penile erection. Pharmacological Reviews, 53(3), 417-450. DOI: https://www.sciencedirect.com/science/article/abs/pii/S0031699724015035

[4] Crowe, M. J. (1991). Pharmacologically induced penile erection (PIPE) as a diagnostic tool in the management of impotence. International Journal of Impotence Research, 3(2), 101-108. DOI: https://www.tandfonline.com/doi/pdf/10.1080/02674659108409604

[5] Padma-Nathan, H. (1987). The pharmacologic erection program. World Journal of Urology, 5(3), 153-157. DOI: https://link.springer.com/article/10.1007/BF00326824

[6] SV Samford Medical. (n.d.). ED Diagnostic - RigiScan Plus. Retrieved from http://medical.svsamford.com/urology/74-ed-diagnostic-rigiscan-rigidity-assessment-system.html

Related Rigicon Products